Skip to main content
Cytosorbents Corp logo

Cytosorbents Corp — Investor Relations & Filings

Ticker · CTSO ISIN · US23283X2062 LEI · 549300VI8WO8GK5QK793 US Manufacturing
Filings indexed 957 across all filing types
Latest filing 2025-05-01 Regulatory Filings
Country US United States of America
Listing US CTSO

About Cytosorbents Corp

https://cytosorbents.com/

Cytosorbents Corporation is a critical care company specializing in blood purification technology to treat life-threatening conditions. Its proprietary platform is based on biocompatible, highly porous polymer beads that use hemoadsorption to remove harmful substances, such as inflammatory mediators and certain drugs, from blood. The company's flagship product, CytoSorb, is an extracorporeal blood purification therapy used in intensive care units and during cardiac surgery to help restore physiological balance. The technology is also applied in other products for ex vivo organ perfusion (ECOS-300CY) and veterinary critical care (VetResQ).

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2025-05-01 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-30 English
ARS
Annual Report
2025-04-23 English
DEFA14A
Regulatory Filings
2025-04-23 English
DEF 14A
Proxy Solicitation & Information Statement
2025-04-23 English
FORM 8-K
Regulatory Filings
2025-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.